Page last updated: 2024-08-05 11:20:29
cyclohexanones
Any alicyclic ketone based on a cyclohexane skeleton and its substituted derivatives thereof.
ChEBI ID: 23482
Members (7)
Member | Definition | Role |
---|---|---|
2-methylcyclohexanone | A member of the class of cyclohexanones that is cyclohexanone substituted by a methyl group at position 2. | 2-methylcyclohexanone |
ascochlorin | A dihydroxybenzaldehyde that is 2,4-dihydroxybenzaldehyde which is substituted by a (1E,3E)-3-methyl-1-[(1R,2R,6R)-1,2,6-trimethyl-3-oxocyclohexyl]penta-1,3-dien-5-yl group at position 3, chlorine at position 5, and a methyl group at position 6. A meroterpenoid produced by several fungi including Ascochyta viciae . It exhibits anticancer, antifungal and antiprotozoal activities. | ascochlorin |
cyclohexanone | A cyclic ketone that consists of cyclohexane bearing a single oxo substituent. | cyclohexanone |
ketamine | A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group. | ketamine |
levodione | A member of the class of cyclohexanones that is cyclohexane-1,4-dionecarrying a gem-dimethyl group at position 2 and an additional methyl substituent at position 6 (the R-enantiomer). | levodione |
nitisinone | A cyclohexanone that is cyclohexane-1,3-dione substituted at position 2 by a 2-nitro-4-(trifluoromethyl)benzoyl group. It is used in the treatment of hereditary tyrosinemia type 1. | nitisinone |
sulcotrione | An aromatic ketone that is cyclohexane-1,3-dione substituted by a 2-chloro-4-(methylsulfonyl)benzoyl group at position 2. | sulcotrione |
Research
Studies (14,523)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 2,651 (18.25) | 18.7374 |
1990's | 1,800 (12.39) | 18.2507 |
2000's | 2,706 (18.63) | 29.6817 |
2010's | 4,817 (33.17) | 24.3611 |
2020's | 2,549 (17.55) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 2,335 (14.88%) | 5.53% |
Reviews | 1,501 (9.57%) | 6.00% |
Case Studies | 1,028 (6.55%) | 4.05% |
Observational | 100 (0.64%) | 0.25% |
Other | 10,726 (68.36%) | 84.16% |